Clinical Trial Update: Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer [Phase 1]

View source ↗

Summary

Phase I study assessing safety and feasibility of combining olaparib with cisplatin-based chemoradiotherapy for locally advanced head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Lynparza (olaparib)
• Platinol (cisplatin)

Snippet

Sponsor: University College, London | Conditions: Head and Neck Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING